Latest On REGENXBIO Inc (RGNX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-23 17:08 EST | News | Regenxbio's gene therapy for Hunter syndrome gets FDA regenerative medicine status | N/A |  |
| 2023-05-12 13:54 EST | News | Regenxbio: Buy, High-Potential Stock Stagnant Due To No Near-Term Catalysts | N/A | |
| 2023-05-04 03:36 EST | News | Regenxbio GAAP EPS of -$1.53 misses by $0.14, revenue of $19.14M misses by $12.15M | N/A | |
| 2023-05-04 03:36 EST | News | REGENXBIO Inc. (RGNX) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-03 02:13 EST | News | Regenxbio Q1 2023 Earnings Preview | N/A | |
| 2023-04-11 18:11 EST | News | Regenxbio stock pops on FDA fast track tag for Duchenne gene therapy RGX-202 | N/A | |
| 2023-03-01 00:46 EST | News | Regenxbio GAAP EPS of -$1.38 beats by $0.05, revenue of $31.35M misses by $6.1M | N/A | |
| 2023-03-01 00:46 EST | News | REGENXBIO Inc. (RGNX) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-27 19:10 EST | News | Regenxbio Q4 2022 Earnings Preview | N/A | |
| 2023-02-22 17:10 EST | News | Regenxbio's Vector Technology Will Change Gene Therapy | N/A | |
| 2023-02-22 17:09 EST | News | Regenxbio touts interim results from trial of pediatric rare disease gene therapy | N/A | |
| 2023-02-17 07:13 EST | News | Regenxbio: Flat Price Response To Key Catalysts Confirms Hold | N/A | |
| 2023-02-13 10:49 EST | News | Regenxbio's study shows similar clinical profile of eye drug produced via different methods | N/A | |
| 2023-01-23 18:57 EST | News | Regenxbio begins phase 1/2 trial of Duchenne muscular dystrophy candidate | N/A | |
| 2023-01-10 13:38 EST | News | Regenxbio names Curran Simpson as COO | N/A | |
| 2022-11-21 14:24 EST | News | Regenxbio: Great R&D, Lack Of Near-Term Catalysts | N/A | |
| 2022-11-04 07:46 EST | News | REGENXBIO Inc. (RGNX) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-03 14:46 EST | News | Regenxbio GAAP EPS of -$1.75 misses by $0.26, revenue of $26.5M misses by $4.31M | N/A | |
| 2022-11-03 14:45 EST | News | Regenxbio slumps 17% as Q3 Zolgensma royalty revenue falls, net loss widens | N/A | |
| 2022-11-02 06:09 EST | News | Regenxbio Q3 2022 Earnings Preview | N/A | |
| 2022-10-03 15:46 EST | News | REGENXBIO says additional phase 2 data bolsters RGX-314 for wet macular degeneration | N/A | |
| 2022-10-01 15:17 EST | News | Stocks To Watch: Investors Look For Edges Amid Inflation, Rates, Earnings Challenges | N/A | |
| 2022-09-15 21:34 EST | News | Regenxbio: A Transformative Year | N/A | |
| 2022-08-31 18:25 EST | News | REGENXBIO shares more data for Hunter Syndrome candidate | N/A | |
| 2022-08-29 17:41 EST | News | Regenxbio: Updates To Thesis, Gene Therapy Pioneer Moving To Late-Stage Development | N/A | |
| 2022-08-05 07:16 EST | News | REGENXBIO Inc. (RGNX) CEO Ken Mills on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-04 01:21 EST | News | Regenxbio GAAP EPS of -$1.58 misses by $0.14, revenue of $32.65M beats by $5.87M | N/A | |
| 2022-08-03 10:18 EST | News | Regenxbio to seek FDA's accelerated approval for Hunter Syndrome treatment, shares rise 8% | N/A | |
| 2022-08-02 20:22 EST | News | REGENXBIO (RGNX) Investor Presentation - Slideshow | N/A | |
| 2022-08-02 20:21 EST | News | Regenxbio Q2 2022 Earnings Preview | N/A | |
| 2022-07-13 05:59 EST | News | Regenxbio: Patience And Regular Homework Are Keys | N/A | |
| 2022-06-23 19:14 EST | News | Berenberg initiates coverage on Regenxbio with buy rating | N/A | |
| 2022-06-12 03:09 EST | News | With bluebird bio's success, what are other gene therapies companies to pay attention to? | N/A | |
| 2022-06-10 02:15 EST | News | Regenxbio opens new gene therapy manufacturing facility in Maryland | N/A | |
| 2022-05-14 22:40 EST | News | Stocks To Watch: Retail Heavyweights Report, Block And Moderna Events | N/A | |
| 2022-05-05 09:02 EST | News | Regenxbio GAAP EPS of -$1.79 misses by $0.49, revenue of $22.2M misses by $7.01M | N/A | |
| 2022-05-05 09:02 EST | News | REGENXBIO Inc. (RGNX) CEO Ken Mills on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-03 19:54 EST | News | Regenxbio Q1 2022 Earnings Preview | N/A | |
| 2022-04-20 18:04 EST | News | Regenxbio: Is The Ultimate Catalyst Coming? | N/A | |
| 2022-03-08 19:04 EST | News | Regenxbio: Suprachoroidal Data Is Still The Key | N/A | |
| 2022-03-02 22:40 EST | News | Regenxbio gains the most in five months on the launch of “5x25 strategy” | N/A | |
| 2022-03-02 05:58 EST | News | Regenxbio GAAP EPS of $6.67 beats by $2.93, revenue of $398.65M beats by $142.89M | N/A | |
| 2022-03-02 05:58 EST | News | Regenxbio stock unchanged after hours despite bottom and top line beats | N/A | |
| 2022-03-02 05:58 EST | News | REGENXBIO's (RGNX) CEO Ken Mills on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-28 17:57 EST | News | Regenxbio Q4 2021 Earnings Preview | N/A | |
| 2022-02-09 17:46 EST | News | REGENXBIO posts early data from Phase I/II trial for RGX-111 in Mucopolysaccharidosis | N/A | |
| 2022-01-06 17:34 EST | News | Regenxbio on go with mid-stage RGX-202 trial for Duchenne muscular dystrophy | N/A | |
| 2021-12-27 00:45 EST | News | Regenxbio: Accumulating For The Long Haul | N/A | |
| 2021-12-22 23:21 EST | News | Citizen Petition asks FDA to block Regenxbio patent extension for Zolgensma | N/A | |
| 2021-11-23 07:18 EST | News | Orphan Drug Designation granted for REGENXBIO Duchennne muscular dystrophy treatment | N/A | |
About REGENXBIO Inc (RGNX):
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's lead product candidate is RGX-314, which is in Phase I/IIa clinical trial for the treatment of wet age-related macular degeneration. It is also developing RGX-121 that is in Phase I/II clinical trial to treat mucopolysaccharidosis type II; RGX-111, which is in Phase I clinical trial for treating mucopolysaccharidosis type I; RGX-181 for the treatment of late-infantile neuronal ceroid lipofuscinosis type II disease; and RGX-501, which is in Phase I/II clinical trials to treat homozygous familial hypercholesterolemia. REGENXBIO Inc. also licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies; and has a collaboration and license agreement with Neurimmune AG to develop vectorized antibodies for the treatment of neurodegenerative diseases. The company was formerly known as ReGenX Biosciences, LLC and changed its name to REGENXBIO Inc. in September 2014. REGENXBIO Inc. was founded in 2008 and is headquartered in Rockville, Maryland.
General
- Name REGENXBIO Inc
- Symbol RGNX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 306
- Fiscal Year EndDecember
- IPO Date2015-09-17
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.regenxbio.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 9.47
- Price/Book (Most Recent Quarter) 4.42
- Enterprise Value Revenue 8.19
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$5.06
- Next Year EPS Estimate -$5.20
- Next Quarter EPS Estimate -$1.32
- Profit Margin -72%
- Operating Margin -77%
- Return on Assets -12%
- Return on Equity -27%
- Revenue 154.57 million
- Earnings Per Share -$1.36
- Revenue Per Share $4.15
- Gross Profit -47441000
- Quarterly Earnings Growth 82.2%
View More
Highlights
- Market Capitalization 1.78 billion
- EBITDA -87438000
- PE Ratio -2.51
- PEG Ratio 0.26
- Analyst Target Price $63.22
- Book Value Per Share $10.08
View More
Share Statistics
- Shares Outstanding 42.5 million
- Shares Float 36.95 million
- % Held by Insiders 1454%
- % Held by Institutions 89.9%
- Shares Short 2.94 million
- Shares Short Prior Month 2.66 million
- Short Ratio 7.52
- Short % of Float 10%
- Short % of Shares Outstanding 7%
View More
Technicals
- Beta 1.2
- 52 Week High $50.26
- 52 Week Low $25.93
- 50 Day Moving Average 42.78
- 200 Day Moving Average 37.27
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
REGENXBIO Inc (RGNX) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
REGENXBIO Inc (RGNX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-01 | $21.45 million | -$1.24 | -$1.17 | -6.28% |
| 2020-09-30 | 2020-11-04 | $N/A | $0.23 | -$0.89 | 125.73% |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.91 | -$0.85 | -6.81% |
| 2020-03-31 | 2020-05-07 | $17.64 million | -$1.08 | -$0.87 | -24.86% |
| 2019-12-31 | 2020-02-26 | $11.77 million | -$0.72 | -$0.40 | -78.53% |
| 2019-09-30 | 2019-11-05 | $14.7 million | -$0.94 | -$0.91 | -3.67% |
| 2019-06-30 | 2019-08-07 | $7.88 million | -$0.04 | -$0.75 | 94.64% |
| 2019-03-31 | 2019-05-07 | $884000 | -$0.89 | -$0.85 | -5.11% |
| 2018-12-31 | 2019-02-27 | $40.78 million | $0.11 | -$0.34 | 132.67% |
| 2018-09-30 | 2018-11-07 | $5.31 million | -$0.56 | -$0.86 | 34.88% |
| 2018-06-30 | 2018-08-08 | $40.03 million | $0.30 | $1.23 | -75.61% |
| 2018-03-31 | 2018-05-08 | $132.39 million | $3.04 | $1.60 | 90.6% |
| 2017-12-31 | 2018-03-06 | $2.04 million | -$0.51 | -$0.82 | 37.42% |
| 2017-09-30 | 2017-11-08 | $1.34 million | -$0.67 | -$0.72 | 6.94% |
| 2017-06-30 | 2017-08-08 | $6.56 million | -$0.47 | -$0.80 | 41.25% |
| 2017-03-31 | 2017-05-09 | $455000 | -$0.82 | -$0.76 | -8.37% |
| 2016-12-31 | 2017-03-07 | $1.7 million | -$0.74 | -$0.60 | -24.37% |
| 2016-09-30 | 2016-11-09 | $125000 | -$0.69 | -$0.60 | -15% |
| 2016-06-30 | 2016-08-09 | $2.38 million | -$0.55 | -$0.52 | -6.8% |
| 2016-03-31 | 2016-05-05 | $393000 | -$0.41 | -$0.45 | 8.89% |
| 2015-12-31 | 2016-03-03 | $4.44 million | -$0.20 | -$0.33 | 39.39% |
| 2015-09-30 | 2015-11-05 | $1.15 million | -$1.52 |
REGENXBIO Inc (RGNX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
REGENXBIO Inc (RGNX) Chart:
REGENXBIO Inc (RGNX) News:
Below you will find a list of latest news for REGENXBIO Inc (RGNX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
REGENXBIO Inc (RGNX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-05-16 | 2.5 | 0 | CALL | 0 | 0 | 886.51 | TRUE | 0 | 0 |
| 2025-05-16 | 5 | 1.7 | CALL | 0 | 2 | 298.23 | TRUE | 0 | 0 |
| 2025-05-16 | 7.5 | 1.9 | CALL | 1 | 307 | 91.71 | TRUE | 0.2 | 0.12 |
| 2025-05-16 | 10 | 0.35 | CALL | 0 | 168 | 79.97 | FALSE | 0 | 0 |
| 2025-05-16 | 12.5 | 0.15 | CALL | 0 | 4 | 153.55 | FALSE | 0 | 0 |
| 2025-05-16 | 15 | 0 | CALL | 0 | 0 | 112.19 | FALSE | 0 | 0 |
| 2025-05-16 | 17.5 | 0 | CALL | 0 | 0 | 472.02 | FALSE | 0 | 0 |
| 2025-05-16 | 2.5 | 0 | PUT | 0 | 0 | 495.83 | FALSE | 0 | 0 |
| 2025-05-16 | 5 | 0.15 | PUT | 0 | 2 | 283.77 | FALSE | 0 | 0 |
| 2025-05-16 | 7.5 | 2.42 | PUT | 0 | 6 | 85.73 | FALSE | 0 | 0 |
| 2025-05-16 | 10 | 0 | PUT | 0 | 0 | 99.86 | TRUE | 0 | 0 |
| 2025-05-16 | 12.5 | 0 | PUT | 0 | 0 | 146.94 | TRUE | 0 | 0 |
| 2025-05-16 | 15 | 0 | PUT | 0 | 0 | 271.83 | TRUE | 0 | 0 |
| 2025-05-16 | 17.5 | 0 | PUT | 0 | 0 | 271.97 | TRUE | 0 | 0 |
| 2025-06-20 | 2.5 | 0 | CALL | 0 | 0 | 248.58 | TRUE | 0 | 0 |
| 2025-06-20 | 5 | 0 | CALL | 0 | 0 | 346.84 | TRUE | 0 | 0 |
| 2025-06-20 | 7.5 | 0 | CALL | 0 | 0 | 108.24 | TRUE | 0 | 0 |
| 2025-06-20 | 10 | 0 | CALL | 0 | 0 | 97.61 | FALSE | 0 | 0 |
| 2025-06-20 | 12.5 | 0 | CALL | 0 | 0 | 235.65 | FALSE | 0 | 0 |
| 2025-06-20 | 15 | 0 | CALL | 0 | 0 | 123.21 | FALSE | 0 | 0 |
| 2025-06-20 | 17.5 | 0 | CALL | 0 | 0 | 292.6 | FALSE | 0 | 0 |
| 2025-06-20 | 2.5 | 0 | PUT | 0 | 0 | 308.89 | FALSE | 0 | 0 |
| 2025-06-20 | 5 | 0 | PUT | 0 | 0 | 161.96 | FALSE | 0 | 0 |
| 2025-06-20 | 7.5 | 0 | PUT | 0 | 0 | 245.86 | FALSE | 0 | 0 |
| 2025-06-20 | 10 | 0 | PUT | 0 | 0 | 138.1 | TRUE | 0 | 0 |
| 2025-06-20 | 12.5 | 0 | PUT | 0 | 0 | 100.21 | TRUE | 0 | 0 |
| 2025-06-20 | 15 | 0 | PUT | 0 | 0 | 168.09 | TRUE | 0 | 0 |
| 2025-06-20 | 17.5 | 0 | PUT | 0 | 0 | 150.72 | TRUE | 0 | 0 |
| 2025-07-18 | 2.5 | 5.9 | CALL | 0 | 5 | 165.35 | TRUE | 0 | 0 |
| 2025-07-18 | 5 | 3.9 | CALL | 0 | 3 | 154.61 | TRUE | 0 | 0 |
| 2025-07-18 | 7.5 | 2.1 | CALL | 1 | 400 | 91.18 | TRUE | -0.11 | -0.05 |
| 2025-07-18 | 10 | 1.15 | CALL | 0 | 523 | 76.46 | FALSE | 0 | 0 |
| 2025-07-18 | 12.5 | 0.72 | CALL | 0 | 22 | 100.9 | FALSE | 0 | 0 |
| 2025-07-18 | 15 | 0.15 | CALL | 2 | 32 | 71.45 | FALSE | 0.15 | 0 |
| 2025-07-18 | 17.5 | 0.7 | CALL | 0 | 3 | 95.82 | FALSE | 0 | 0 |
| 2025-07-18 | 20 | 0 | CALL | 0 | 0 | 255.73 | FALSE | 0 | 0 |
| 2025-07-18 | 22.5 | 0.08 | CALL | 0 | 37 | 269.62 | FALSE | 0 | 0 |
| 2025-07-18 | 2.5 | 0 | PUT | 0 | 0 | 1107.51 | FALSE | 0 | 0 |
| 2025-07-18 | 5 | 0.3 | PUT | 0 | 6 | 361.86 | FALSE | 0 | 0 |
| 2025-07-18 | 7.5 | 2.55 | PUT | 0 | 73 | 96.36 | FALSE | 0 | 0 |
| 2025-07-18 | 10 | 4.3 | PUT | 0 | 12 | 57.38 | TRUE | 0 | 0 |
| 2025-07-18 | 12.5 | 4.5 | PUT | 0 | 51 | 85.29 | TRUE | 0 | 0 |
| 2025-07-18 | 15 | 8.3 | PUT | 0 | 0 | 103.01 | TRUE | 0 | 0 |
| 2025-07-18 | 17.5 | 0 | PUT | 0 | 0 | 143.77 | TRUE | 0 | 0 |
| 2025-07-18 | 20 | 0 | PUT | 0 | 0 | 133.46 | TRUE | 0 | 0 |
| 2025-07-18 | 22.5 | 0 | PUT | 0 | 0 | 131.9 | TRUE | 0 | 0 |
| 2025-10-17 | 2.5 | 3 | CALL | 0 | 1 | 406.46 | TRUE | 0 | 0 |
| 2025-10-17 | 5 | 4 | CALL | 0 | 26 | 76.06 | TRUE | 0 | 0 |
| 2025-10-17 | 7.5 | 1.5 | CALL | 0 | 60 | 82.24 | TRUE | 0 | 0 |
| 2025-10-17 | 10 | 1.05 | CALL | 20 | 552 | 88.23 | FALSE | -0.45 | -0.3 |
| 2025-10-17 | 12.5 | 0.5 | CALL | 0 | 301 | 69.01 | FALSE | 0 | 0 |
| 2025-10-17 | 15 | 0.7 | CALL | 0 | 36 | 70.21 | FALSE | 0 | 0 |
| 2025-10-17 | 17.5 | 0 | CALL | 0 | 0 | 90.52 | FALSE | 0 | 0 |
| 2025-10-17 | 2.5 | 0 | PUT | 0 | 0 | 812 | FALSE | 0 | 0 |
| 2025-10-17 | 5 | 0.4 | PUT | 0 | 64 | 95.88 | FALSE | 0 | 0 |
| 2025-10-17 | 7.5 | 1.8 | PUT | 0 | 392 | 80.81 | FALSE | 0 | 0 |
| 2025-10-17 | 10 | 2.9 | PUT | 0 | 352 | 78.54 | TRUE | 0 | 0 |
| 2025-10-17 | 12.5 | 4.54 | PUT | 0 | 9 | 79.56 | TRUE | 0 | 0 |
| 2025-10-17 | 15 | 0 | PUT | 0 | 0 | 96.57 | TRUE | 0 | 0 |
| 2025-10-17 | 17.5 | 0 | PUT | 0 | 0 | 111.4 | TRUE | 0 | 0 |
Latest RGNX Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 7 | $19.69 |
| Jun 13, 2022 7:59 PM EST | 1 | $19.68 |
| Jun 13, 2022 7:59 PM EST | 1 | $19.68 |
| Jun 13, 2022 7:59 PM EST | 12 | $19.68 |
| Jun 13, 2022 7:59 PM EST | 6 | $19.67 |
REGENXBIO Inc (RGNX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1590877/000119312520185954/0001193125-20-185954-index.htm |
| 2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1590877/000009375119000165/0000093751-19-000165-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1590877/000009375120000551/0000093751-20-000551-index.htm |
| 2019-01-31 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1590877/000021545719002614/0000215457-19-002614-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1590877/000031506619001295/0000315066-19-001295-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1590877/000083423720002781/0000834237-20-002781-index.htm |
| 2020-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000089924320025725/0000899243-20-025725-index.htm |
| 2019-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1590877/000093247119005789/0000932471-19-005789-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1590877/000110465920017826/0001104659-20-017826-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1590877/000110465920021827/0001104659-20-021827-index.htm |
| 2018-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1590877/000119312518319055/0001193125-18-319055-index.htm |
| 2019-01-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1590877/000119312519001555/0001193125-19-001555-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1590877/000119312519040856/0001193125-19-040856-index.htm |
| 2019-04-11 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1590877/000119312519103878/0001193125-19-103878-index.htm |
| 2019-04-11 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1590877/000119312519103879/0001193125-19-103879-index.htm |
| 2019-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1590877/000119312519164137/0001193125-19-164137-index.htm |
| 2019-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1590877/000119312519266891/0001193125-19-266891-index.htm |
| 2020-01-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1590877/000119312520004236/0001193125-20-004236-index.htm |
| 2020-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1590877/000119312520035624/0001193125-20-035624-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1590877/000119312520035640/0001193125-20-035640-index.htm |
| 2020-03-06 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1590877/000119312520065103/0001193125-20-065103-index.htm |
| 2020-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1590877/000119312520157279/0001193125-20-157279-index.htm |
| 2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1590877/000119312520185954/0001193125-20-185954-index.htm |
| 2020-09-18 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1590877/000119312520249155/0001193125-20-249155-index.htm |
| 2020-10-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1590877/000119312520277495/0001193125-20-277495-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1590877/000149315219001954/0001493152-19-001954-index.htm |
| 2018-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004417/0001562180-18-004417-index.htm |
| 2018-11-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004451/0001562180-18-004451-index.htm |
| 2018-11-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004452/0001562180-18-004452-index.htm |
| 2018-11-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004476/0001562180-18-004476-index.htm |
| 2018-11-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004532/0001562180-18-004532-index.htm |
| 2018-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004611/0001562180-18-004611-index.htm |
| 2018-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004631/0001562180-18-004631-index.htm |
| 2018-11-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004642/0001562180-18-004642-index.htm |
| 2018-11-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm |
| 2018-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004678/0001562180-18-004678-index.htm |
| 2018-11-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004726/0001562180-18-004726-index.htm |
| 2018-11-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004727/0001562180-18-004727-index.htm |
| 2018-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004775/0001562180-18-004775-index.htm |
| 2018-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004807/0001562180-18-004807-index.htm |
| 2018-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004849/0001562180-18-004849-index.htm |
| 2018-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004850/0001562180-18-004850-index.htm |
| 2018-12-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218018005050/0001562180-18-005050-index.htm |
| 2018-12-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218018005051/0001562180-18-005051-index.htm |
| 2018-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218018005060/0001562180-18-005060-index.htm |
| 2019-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019000218/0001562180-19-000218-index.htm |
| 2019-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019000219/0001562180-19-000219-index.htm |
| 2019-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019000220/0001562180-19-000220-index.htm |
| 2019-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019000221/0001562180-19-000221-index.htm |
| 2019-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019000222/0001562180-19-000222-index.htm |
| 2019-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019000337/0001562180-19-000337-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019000759/0001562180-19-000759-index.htm |
| 2019-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019000815/0001562180-19-000815-index.htm |
| 2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019000874/0001562180-19-000874-index.htm |
| 2019-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019001047/0001562180-19-001047-index.htm |
| 2019-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019001472/0001562180-19-001472-index.htm |
| 2019-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019001801/0001562180-19-001801-index.htm |
| 2019-03-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019001906/0001562180-19-001906-index.htm |
| 2019-03-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002005/0001562180-19-002005-index.htm |
| 2019-03-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002018/0001562180-19-002018-index.htm |
| 2019-04-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002295/0001562180-19-002295-index.htm |
| 2019-04-19 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002310/0001562180-19-002310-index.htm |
| 2019-04-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002311/0001562180-19-002311-index.htm |
| 2019-04-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002324/0001562180-19-002324-index.htm |
| 2019-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002331/0001562180-19-002331-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003056/0001562180-19-003056-index.htm |
| 2019-05-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003180/0001562180-19-003180-index.htm |
| 2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003290/0001562180-19-003290-index.htm |
| 2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003291/0001562180-19-003291-index.htm |
| 2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003292/0001562180-19-003292-index.htm |
| 2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003293/0001562180-19-003293-index.htm |
| 2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003295/0001562180-19-003295-index.htm |
| 2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003296/0001562180-19-003296-index.htm |
| 2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003297/0001562180-19-003297-index.htm |
| 2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003298/0001562180-19-003298-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003602/0001562180-19-003602-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003604/0001562180-19-003604-index.htm |
| 2019-07-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004025/0001562180-19-004025-index.htm |
| 2019-07-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004035/0001562180-19-004035-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004433/0001562180-19-004433-index.htm |
| 2019-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004820/0001562180-19-004820-index.htm |
| 2019-09-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004927/0001562180-19-004927-index.htm |
| 2019-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218019006017/0001562180-19-006017-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000214/0001562180-20-000214-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000216/0001562180-20-000216-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000217/0001562180-20-000217-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000218/0001562180-20-000218-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000219/0001562180-20-000219-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000220/0001562180-20-000220-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000321/0001562180-20-000321-index.htm |
| 2020-01-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000391/0001562180-20-000391-index.htm |
| 2020-01-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000452/0001562180-20-000452-index.htm |
| 2020-01-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000453/0001562180-20-000453-index.htm |
| 2020-01-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000454/0001562180-20-000454-index.htm |
| 2020-01-28 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000618/0001562180-20-000618-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001013/0001562180-20-001013-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001014/0001562180-20-001014-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001015/0001562180-20-001015-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001108/0001562180-20-001108-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001111/0001562180-20-001111-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001112/0001562180-20-001112-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020002850/0001562180-20-002850-index.htm |
| 2020-04-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020003177/0001562180-20-003177-index.htm |
| 2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020003531/0001562180-20-003531-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020004062/0001562180-20-004062-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020004063/0001562180-20-004063-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020004064/0001562180-20-004064-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020004065/0001562180-20-004065-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020004066/0001562180-20-004066-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020004069/0001562180-20-004069-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020004070/0001562180-20-004070-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020004071/0001562180-20-004071-index.htm |
| 2020-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1590877/000156218020005162/0001562180-20-005162-index.htm |
| 2018-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1590877/000156459018028022/0001564590-18-028022-index.htm |
| 2018-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1590877/000156459018028054/0001564590-18-028054-index.htm |
| 2019-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1590877/000156459019004898/0001564590-19-004898-index.htm |
| 2019-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1590877/000156459019004920/0001564590-19-004920-index.htm |
| 2019-02-27 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1590877/000156459019004925/0001564590-19-004925-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1590877/000156459019016503/0001564590-19-016503-index.htm |
| 2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1590877/000156459019016531/0001564590-19-016531-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1590877/000156459019030062/0001564590-19-030062-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1590877/000156459019030100/0001564590-19-030100-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1590877/000156459019040379/0001564590-19-040379-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1590877/000156459019040403/0001564590-19-040403-index.htm |
| 2020-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1590877/000156459020006781/0001564590-20-006781-index.htm |
| 2020-02-26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1590877/000156459020006826/0001564590-20-006826-index.htm |
| 2020-02-26 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1590877/000156459020006829/0001564590-20-006829-index.htm |
| 2020-04-08 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1590877/000156459020015913/0001564590-20-015913-index.htm |
| 2020-04-08 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1590877/000156459020015924/0001564590-20-015924-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1590877/000156459020022854/0001564590-20-022854-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1590877/000156459020022890/0001564590-20-022890-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1590877/000156459020037734/0001564590-20-037734-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1590877/000156459020037775/0001564590-20-037775-index.htm |
| 2020-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1590877/000156459020050477/0001564590-20-050477-index.htm |
| 2020-11-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1590877/000156459020050485/0001564590-20-050485-index.htm |
| 2019-04-03 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1590877/999999999719002260/9999999997-19-002260-index.htm |
| 2019-09-23 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1590877/999999999719007068/9999999997-19-007068-index.htm |
| 2019-09-30 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1590877/999999999719007166/9999999997-19-007166-index.htm |
REGENXBIO Inc (RGNX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of REGENXBIO Inc (RGNX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1454%Institutional Ownership: 8990%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-01-14 | DONALD J JR HAYDEN | Director | Sell | 30,000.00 | 45.60 | 1,368,000.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000391/0001562180-20-000391-index.htm |
| 2020-01-17 | DONALD J JR HAYDEN | Director | Sell | 3,200.00 | 50.01 | 160,032.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000452/0001562180-20-000452-index.htm |
| 2020-02-05 | DONALD J JR HAYDEN | Director | Sell | 2,000.00 | 50.00 | 100,000.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001013/0001562180-20-001013-index.htm |
| 2020-02-10 | DONALD J JR HAYDEN | Director | Sell | 24,800.00 | 50.11 | 1,242,728.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001108/0001562180-20-001108-index.htm |
| 2018-11-19 | LUKE M BESHAR | Director | Sell | 600.00 | 63.53 | 38,118.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm |
| 2018-11-20 | LUKE M BESHAR | Director | Sell | 21,176.00 | 60.38 | 1,278,606.88 | 0.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm |
| 2018-11-26 | LUKE M BESHAR | Director | Sell | 1,721.00 | 65.00 | 111,865.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004727/0001562180-18-004727-index.htm |
| 2018-11-27 | LUKE M BESHAR | Director | Sell | 18,786.00 | 65.03 | 1,221,653.58 | 0.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004727/0001562180-18-004727-index.htm |
| 2018-11-29 | LUKE M BESHAR | Director | Sell | 12,784.00 | 65.00 | 830,960.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004775/0001562180-18-004775-index.htm |
| 2018-11-05 | Stephen Yoo | Chief Medical Officer | Sell | 4,627.00 | 69.97 | 323,751.19 | 0.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004452/0001562180-18-004452-index.htm |
| 2018-11-19 | Stephen Yoo | Chief Medical Officer | Sell | 1,100.00 | 63.21 | 69,531.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004642/0001562180-18-004642-index.htm |
| 2018-12-03 | Stephen Yoo | Chief Medical Officer | Sell | 507.00 | 61.20 | 31,028.40 | 0.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004850/0001562180-18-004850-index.htm |
| 2018-11-19 | Stephen Yoo | Chief Medical Officer | Sell | 800.00 | 61.55 | 49,240.00 | 1,100.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004642/0001562180-18-004642-index.htm |
| 2018-11-27 | LUKE M BESHAR | Director | Buy | 6,250.00 | 18.85 | 117,812.50 | 11,820.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004727/0001562180-18-004727-index.htm |
| 2018-11-19 | LUKE M BESHAR | Director | Sell | 10,916.00 | 60.26 | 657,798.16 | 1,200.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm |
| 2018-11-19 | LUKE M BESHAR | Director | Buy | 3,262.00 | 12.74 | 41,557.88 | 12,116.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm |
| 2018-11-05 | Stephen Yoo | Chief Medical Officer | Sell | 4,820.00 | 67.14 | 323,614.80 | 12,181.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004452/0001562180-18-004452-index.htm |
| 2018-12-17 | Vittal Vasista | Chief Financial Officer | Sell | 1,700.00 | 47.74 | 81,158.00 | 122,283.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018005051/0001562180-18-005051-index.htm |
| 2018-12-17 | Vittal Vasista | Chief Financial Officer | Sell | 1,700.00 | 46.47 | 78,999.00 | 123,983.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018005051/0001562180-18-005051-index.htm |
| 2018-12-17 | Vittal Vasista | Chief Financial Officer | Sell | 4,100.00 | 45.73 | 187,493.00 | 125,683.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018005051/0001562180-18-005051-index.htm |
| 2018-11-29 | LUKE M BESHAR | Director | Buy | 12,784.00 | 3.76 | 48,067.84 | 12,784.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004775/0001562180-18-004775-index.htm |
| 2018-11-15 | Vittal Vasista | Chief Financial Officer | Sell | 100.00 | 64.10 | 6,410.00 | 129,783.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004611/0001562180-18-004611-index.htm |
| 2018-11-15 | Vittal Vasista | Chief Financial Officer | Sell | 700.00 | 63.05 | 44,135.00 | 129,883.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004611/0001562180-18-004611-index.htm |
| 2018-11-15 | Vittal Vasista | Chief Financial Officer | Sell | 2,042.00 | 62.23 | 127,073.66 | 130,583.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004611/0001562180-18-004611-index.htm |
| 2018-11-15 | Vittal Vasista | Chief Financial Officer | Sell | 588.00 | 60.40 | 35,515.20 | 132,625.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004611/0001562180-18-004611-index.htm |
| 2018-11-15 | Vittal Vasista | Chief Financial Officer | Sell | 1,900.00 | 59.06 | 112,214.00 | 133,213.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004611/0001562180-18-004611-index.htm |
| 2018-11-15 | Vittal Vasista | Chief Financial Officer | Sell | 2,170.00 | 58.46 | 126,858.20 | 135,113.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004611/0001562180-18-004611-index.htm |
| 2018-12-03 | Stephen Yoo | Chief Medical Officer | Sell | 6,854.00 | 59.62 | 408,635.48 | 13,560.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004850/0001562180-18-004850-index.htm |
| 2018-11-01 | Vittal Vasista | Chief Financial Officer | Sell | 19,677.00 | 70.04 | 1,378,177.08 | 137,283.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004417/0001562180-18-004417-index.htm |
| 2018-11-02 | Vittal Vasista | Chief Financial Officer | Sell | 53,741.00 | 70.26 | 3,775,842.66 | 137,283.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004417/0001562180-18-004417-index.htm |
| 2018-11-01 | Vittal Vasista | Chief Financial Officer | Buy | 9,959.00 | 3.76 | 37,445.84 | 147,242.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004417/0001562180-18-004417-index.htm |
| 2018-11-30 | Olivier Danos | Chief Scientific Officer | Buy | 1,500.00 | 20.35 | 30,525.00 | 1,500.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004807/0001562180-18-004807-index.htm |
| 2018-11-19 | Stephen Yoo | Chief Medical Officer | Sell | 2,300.00 | 58.37 | 134,251.00 | 15,353.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004642/0001562180-18-004642-index.htm |
| 2018-11-01 | Vittal Vasista | Chief Financial Officer | Buy | 9,718.00 | 13.09 | 127,208.62 | 156,960.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004417/0001562180-18-004417-index.htm |
| 2020-02-11 | Curran Simpson | SVP, Product Development & CTO | Buy | 6,633.00 | 22.00 | 145,926.00 | 16,512.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001112/0001562180-20-001112-index.htm |
| 2018-11-05 | Stephen Yoo | Chief Medical Officer | Sell | 3,413.00 | 66.26 | 226,145.38 | 17,001.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004452/0001562180-18-004452-index.htm |
| 2018-11-02 | Vittal Vasista | Chief Financial Officer | Buy | 32,908.00 | 13.09 | 430,765.72 | 170,191.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004417/0001562180-18-004417-index.htm |
| 2018-11-26 | LUKE M BESHAR | Director | Buy | 1,721.00 | 49.45 | 85,103.45 | 1,721.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004727/0001562180-18-004727-index.htm |
| 2018-11-19 | Stephen Yoo | Chief Medical Officer | Sell | 2,761.00 | 57.08 | 157,597.88 | 17,653.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004642/0001562180-18-004642-index.htm |
| 2018-11-27 | LUKE M BESHAR | Director | Buy | 6,250.00 | 12.74 | 79,625.00 | 18,070.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004727/0001562180-18-004727-index.htm |
| 2018-11-27 | LUKE M BESHAR | Director | Buy | 716.00 | 3.76 | 2,692.16 | 18,786.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004727/0001562180-18-004727-index.htm |
| 2018-11-19 | Stephen Yoo | Chief Medical Officer | Sell | 4,361.00 | 60.25 | 262,750.25 | 1,900.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004642/0001562180-18-004642-index.htm |
| 2018-11-02 | Vittal Vasista | Chief Financial Officer | Buy | 20,833.00 | 19.50 | 406,243.50 | 191,024.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004417/0001562180-18-004417-index.htm |
| 2020-07-15 | Vittal Vasista | Chief Financial Officer | Sell | 14,950.00 | 40.10 | 599,495.00 | 195,024.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020005162/0001562180-20-005162-index.htm |
| 2020-02-05 | DONALD J JR HAYDEN | Director | Buy | 2,000.00 | 0.85 | 1,700.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001013/0001562180-20-001013-index.htm |
| 2019-01-15 | Kenneth T. Mills | President and CEO | Sell | 3,140.00 | 44.40 | 139,416.00 | 201,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019000337/0001562180-19-000337-index.htm |
| 2018-11-05 | Stephen Yoo | Chief Medical Officer | Buy | 20,414.00 | 0.85 | 17,351.90 | 20,414.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004452/0001562180-18-004452-index.htm |
| 2018-11-19 | Stephen Yoo | Chief Medical Officer | Buy | 20,414.00 | 0.85 | 17,351.90 | 20,414.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004642/0001562180-18-004642-index.htm |
| 2018-12-03 | Stephen Yoo | Chief Medical Officer | Buy | 20,414.00 | 0.85 | 17,351.90 | 20,414.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004850/0001562180-18-004850-index.htm |
| 2019-01-15 | Kenneth T. Mills | President and CEO | Sell | 11,860.00 | 43.70 | 518,282.00 | 204,140.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019000337/0001562180-19-000337-index.htm |
| 2020-05-08 | Vittal Vasista | Chief Financial Officer | Sell | 7,000.00 | 40.18 | 281,260.00 | 206,715.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020003531/0001562180-20-003531-index.htm |
| 2020-05-11 | Vittal Vasista | Chief Financial Officer | Sell | 500.00 | 40.00 | 20,000.00 | 206,715.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020003531/0001562180-20-003531-index.htm |
| 2020-05-11 | Vittal Vasista | Chief Financial Officer | Buy | 500.00 | 13.09 | 6,545.00 | 207,215.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020003531/0001562180-20-003531-index.htm |
| 2020-07-15 | Vittal Vasista | Chief Financial Officer | Buy | 3,259.00 | 13.09 | 42,660.31 | 209,974.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020005162/0001562180-20-005162-index.htm |
| 2020-02-10 | Vittal Vasista | Chief Financial Officer | Sell | 14,129.00 | 50.12 | 708,145.48 | 210,215.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001111/0001562180-20-001111-index.htm |
| 2020-04-24 | Vittal Vasista | Chief Financial Officer | Sell | 12,000.00 | 40.11 | 481,320.00 | 211,215.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020003177/0001562180-20-003177-index.htm |
| 2018-11-20 | LUKE M BESHAR | Director | Buy | 13,500.00 | 3.76 | 50,760.00 | 21,176.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm |
| 2020-05-08 | Vittal Vasista | Chief Financial Officer | Buy | 2,500.00 | 13.09 | 32,725.00 | 213,715.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020003531/0001562180-20-003531-index.htm |
| 2018-12-17 | Kenneth T. Mills | President and CEO | Sell | 4,408.00 | 47.74 | 210,437.92 | 216,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018005050/0001562180-18-005050-index.htm |
| 2020-03-31 | Vittal Vasista | Chief Financial Officer | Buy | 10,000.00 | 0.85 | 8,500.00 | 220,215.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020002850/0001562180-20-002850-index.htm |
| 2020-04-23 | Vittal Vasista | Chief Financial Officer | Sell | 3,000.00 | 40.00 | 120,000.00 | 220,215.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020003177/0001562180-20-003177-index.htm |
| 2018-12-17 | Kenneth T. Mills | President and CEO | Sell | 2,988.00 | 46.81 | 139,868.28 | 220,408.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018005050/0001562180-18-005050-index.htm |
| 2020-02-05 | Vittal Vasista | Chief Financial Officer | Sell | 300.00 | 50.00 | 15,000.00 | 222,021.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001014/0001562180-20-001014-index.htm |
| 2020-01-17 | Vittal Vasista | Chief Financial Officer | Sell | 2,394.00 | 50.00 | 119,700.00 | 222,321.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000453/0001562180-20-000453-index.htm |
| 2020-04-23 | Vittal Vasista | Chief Financial Officer | Buy | 3,000.00 | 13.09 | 39,270.00 | 223,215.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020003177/0001562180-20-003177-index.htm |
| 2020-04-24 | Vittal Vasista | Chief Financial Officer | Buy | 3,000.00 | 13.09 | 39,270.00 | 223,215.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020003177/0001562180-20-003177-index.htm |
| 2018-12-17 | Kenneth T. Mills | President and CEO | Sell | 7,604.00 | 46.11 | 350,620.44 | 223,396.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018005050/0001562180-18-005050-index.htm |
| 2020-02-10 | Vittal Vasista | Chief Financial Officer | Sell | 677.00 | 49.05 | 33,206.85 | 224,344.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001111/0001562180-20-001111-index.htm |
| 2020-01-08 | Vittal Vasista | Chief Financial Officer | Sell | 5,100.00 | 41.92 | 213,792.00 | 224,715.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000321/0001562180-20-000321-index.htm |
| 2020-02-10 | Vittal Vasista | Chief Financial Officer | Buy | 3,000.00 | 13.09 | 39,270.00 | 225,021.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001111/0001562180-20-001111-index.htm |
| 2020-02-05 | Curran Simpson | SVP, Product Development & CTO | Sell | 5,637.00 | 50.00 | 281,850.00 | 22,648.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001015/0001562180-20-001015-index.htm |
| 2019-03-21 | Vittal Vasista | Chief Financial Officer | Sell | 1,700.00 | 61.31 | 104,227.00 | 229,215.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002018/0001562180-19-002018-index.htm |
| 2020-01-08 | Vittal Vasista | Chief Financial Officer | Sell | 2,400.00 | 41.40 | 99,360.00 | 229,815.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000321/0001562180-20-000321-index.htm |
| 2019-03-21 | Vittal Vasista | Chief Financial Officer | Sell | 8,300.00 | 60.64 | 503,312.00 | 230,915.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002018/0001562180-19-002018-index.htm |
| 2018-12-03 | Kenneth T. Mills | President and CEO | Sell | 1,300.00 | 61.33 | 79,729.00 | 231,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004849/0001562180-18-004849-index.htm |
| 2020-01-17 | Curran Simpson | SVP, Product Development & CTO | Sell | 5,922.00 | 50.00 | 296,100.00 | 23,148.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000454/0001562180-20-000454-index.htm |
| 2020-01-08 | Vittal Vasista | Chief Financial Officer | Buy | 3,000.00 | 13.09 | 39,270.00 | 232,215.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000321/0001562180-20-000321-index.htm |
| 2018-12-03 | Kenneth T. Mills | President and CEO | Sell | 18,700.00 | 60.34 | 1,128,358.00 | 232,300.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004849/0001562180-18-004849-index.htm |
| 2019-03-05 | Vittal Vasista | Chief Financial Officer | Sell | 3,068.00 | 60.01 | 184,110.68 | 239,215.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019001801/0001562180-19-001801-index.htm |
| 2019-12-09 | Curran Simpson | SVP, Product Development & CTO | Sell | 6,153.00 | 44.26 | 272,331.78 | 23,948.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019006017/0001562180-19-006017-index.htm |
| 2019-09-19 | Kenneth T. Mills | President and CEO | Sell | 7,773.00 | 39.91 | 310,220.43 | 241,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004927/0001562180-19-004927-index.htm |
| 2019-02-07 | Vittal Vasista | Chief Financial Officer | Buy | 120,000.00 | 0.85 | 102,000.00 | 242,283.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019000874/0001562180-19-000874-index.htm |
| 2019-02-01 | Kenneth T. Mills | President and CEO | Buy | 45,000.00 | 0.85 | 38,250.00 | 246,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019000759/0001562180-19-000759-index.htm |
| 2019-02-15 | Kenneth T. Mills | President and CEO | Sell | 8,066.00 | 47.84 | 385,877.44 | 246,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019001047/0001562180-19-001047-index.htm |
| 2019-03-19 | Kenneth T. Mills | President and CEO | Sell | 9,130.00 | 58.74 | 536,296.20 | 246,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002005/0001562180-19-002005-index.htm |
| 2019-04-22 | Kenneth T. Mills | President and CEO | Sell | 100.00 | 53.05 | 5,305.00 | 246,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002331/0001562180-19-002331-index.htm |
| 2019-05-20 | Kenneth T. Mills | President and CEO | Sell | 300.00 | 43.99 | 13,197.00 | 246,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003056/0001562180-19-003056-index.htm |
| 2019-06-19 | Kenneth T. Mills | President and CEO | Sell | 4,120.00 | 53.25 | 219,390.00 | 246,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003604/0001562180-19-003604-index.htm |
| 2019-07-19 | Kenneth T. Mills | President and CEO | Sell | 2,300.00 | 49.97 | 114,931.00 | 246,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004035/0001562180-19-004035-index.htm |
| 2019-08-19 | Kenneth T. Mills | President and CEO | Sell | 376.00 | 37.92 | 14,257.92 | 246,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004433/0001562180-19-004433-index.htm |
| 2019-04-22 | Kenneth T. Mills | President and CEO | Sell | 1,300.00 | 52.33 | 68,029.00 | 246,100.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002331/0001562180-19-002331-index.htm |
| 2019-05-20 | Kenneth T. Mills | President and CEO | Sell | 10,559.00 | 43.32 | 457,415.88 | 246,300.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003056/0001562180-19-003056-index.htm |
| 2019-08-19 | Kenneth T. Mills | President and CEO | Sell | 14,624.00 | 37.54 | 548,984.96 | 246,376.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004433/0001562180-19-004433-index.htm |
| 2019-04-22 | Kenneth T. Mills | President and CEO | Sell | 3,270.00 | 51.07 | 166,998.90 | 247,400.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002331/0001562180-19-002331-index.htm |
| 2020-02-10 | DONALD J JR HAYDEN | Director | Buy | 24,800.00 | 0.85 | 21,080.00 | 24,800.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001108/0001562180-20-001108-index.htm |
| 2019-07-19 | Kenneth T. Mills | President and CEO | Sell | 12,700.00 | 49.40 | 627,380.00 | 248,300.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004035/0001562180-19-004035-index.htm |
| 2019-09-19 | Kenneth T. Mills | President and CEO | Sell | 2,227.00 | 39.19 | 87,276.13 | 248,773.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004927/0001562180-19-004927-index.htm |
| 2019-06-19 | Kenneth T. Mills | President and CEO | Sell | 10,880.00 | 52.27 | 568,697.60 | 250,120.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003604/0001562180-19-003604-index.htm |
| 2019-04-22 | Kenneth T. Mills | President and CEO | Sell | 6,929.00 | 50.31 | 348,597.99 | 250,670.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002331/0001562180-19-002331-index.htm |
| 2019-09-19 | Kenneth T. Mills | President and CEO | Buy | 5,000.00 | 0.85 | 4,250.00 | 251,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004927/0001562180-19-004927-index.htm |
| 2018-11-26 | Kenneth T. Mills | President and CEO | Sell | 8,620.00 | 64.64 | 557,196.80 | 251,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004726/0001562180-18-004726-index.htm |
| 2019-02-15 | Kenneth T. Mills | President and CEO | Sell | 3,522.00 | 47.30 | 166,590.60 | 254,066.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019001047/0001562180-19-001047-index.htm |
| 2019-03-19 | Kenneth T. Mills | President and CEO | Sell | 5,870.00 | 58.21 | 341,692.70 | 255,130.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002005/0001562180-19-002005-index.htm |
| 2020-01-17 | Curran Simpson | SVP, Product Development & CTO | Buy | 1,622.00 | 19.50 | 31,629.00 | 25,570.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000454/0001562180-20-000454-index.htm |
| 2019-05-20 | Kenneth T. Mills | President and CEO | Sell | 4,141.00 | 42.08 | 174,253.28 | 256,859.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003056/0001562180-19-003056-index.htm |
| 2019-09-12 | Patrick J. Christmas | SVP, General Counsel | Sell | 5,486.00 | 42.00 | 230,412.00 | 2,572.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004820/0001562180-19-004820-index.htm |
| 2019-02-15 | Kenneth T. Mills | President and CEO | Sell | 3,412.00 | 45.96 | 156,815.52 | 257,588.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019001047/0001562180-19-001047-index.htm |
| 2019-04-22 | Kenneth T. Mills | President and CEO | Sell | 3,401.00 | 49.29 | 167,635.29 | 257,599.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002331/0001562180-19-002331-index.htm |
| 2020-02-05 | Curran Simpson | SVP, Product Development & CTO | Buy | 2,708.00 | 13.09 | 35,447.72 | 25,856.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001015/0001562180-20-001015-index.htm |
| 2018-11-26 | Kenneth T. Mills | President and CEO | Sell | 11,380.00 | 63.81 | 726,157.80 | 259,620.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004726/0001562180-18-004726-index.htm |
| 2018-11-19 | LUKE M BESHAR | Director | Buy | 2,604.00 | 49.45 | 128,767.80 | 2,604.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm |
| 2019-02-14 | Kenneth T. Mills | President and CEO | Buy | 15,000.00 | 0.85 | 12,750.00 | 261,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019001047/0001562180-19-001047-index.htm |
| 2019-03-19 | Kenneth T. Mills | President and CEO | Buy | 15,000.00 | 0.85 | 12,750.00 | 261,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002005/0001562180-19-002005-index.htm |
| 2019-04-22 | Kenneth T. Mills | President and CEO | Buy | 15,000.00 | 0.85 | 12,750.00 | 261,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002331/0001562180-19-002331-index.htm |
| 2019-05-20 | Kenneth T. Mills | President and CEO | Buy | 15,000.00 | 0.85 | 12,750.00 | 261,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003056/0001562180-19-003056-index.htm |
| 2019-06-19 | Kenneth T. Mills | President and CEO | Buy | 15,000.00 | 0.85 | 12,750.00 | 261,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003604/0001562180-19-003604-index.htm |
| 2019-07-19 | Kenneth T. Mills | President and CEO | Buy | 15,000.00 | 0.85 | 12,750.00 | 261,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004035/0001562180-19-004035-index.htm |
| 2019-08-19 | Kenneth T. Mills | President and CEO | Buy | 15,000.00 | 0.85 | 12,750.00 | 261,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004433/0001562180-19-004433-index.htm |
| 2018-11-07 | Patrick J. Christmas | SVP, General Counsel | Sell | 15,000.00 | 72.06 | 1,080,900.00 | 2,669.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004476/0001562180-18-004476-index.htm |
| 2018-12-18 | Patrick J. Christmas | SVP, General Counsel | Sell | 720.00 | 48.97 | 35,258.40 | 2,669.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018005060/0001562180-18-005060-index.htm |
| 2020-02-05 | Curran Simpson | SVP, Product Development & CTO | Buy | 1,000.00 | 19.50 | 19,500.00 | 26,856.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001015/0001562180-20-001015-index.htm |
| 2020-02-10 | Curran Simpson | SVP, Product Development & CTO | Buy | 4,253.00 | 19.50 | 82,933.50 | 26,901.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001112/0001562180-20-001112-index.htm |
| 2018-11-21 | Kenneth T. Mills | President and CEO | Sell | 6,898.00 | 61.92 | 427,124.16 | 271,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004678/0001562180-18-004678-index.htm |
| 2018-11-21 | Kenneth T. Mills | President and CEO | Sell | 6,802.00 | 61.22 | 416,418.44 | 277,898.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004678/0001562180-18-004678-index.htm |
| 2020-02-05 | Curran Simpson | SVP, Product Development & CTO | Buy | 958.00 | 22.00 | 21,076.00 | 27,814.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001015/0001562180-20-001015-index.htm |
| 2020-01-17 | Curran Simpson | SVP, Product Development & CTO | Buy | 2,700.00 | 22.00 | 59,400.00 | 28,270.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000454/0001562180-20-000454-index.htm |
| 2020-02-05 | Curran Simpson | SVP, Product Development & CTO | Buy | 471.00 | 35.80 | 16,861.80 | 28,285.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001015/0001562180-20-001015-index.htm |
| 2018-11-21 | Kenneth T. Mills | President and CEO | Sell | 1,300.00 | 60.09 | 78,117.00 | 284,700.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004678/0001562180-18-004678-index.htm |
| 2018-11-12 | Kenneth T. Mills | President and CEO | Sell | 200.00 | 64.30 | 12,860.00 | 286,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004532/0001562180-18-004532-index.htm |
| 2018-11-12 | Kenneth T. Mills | President and CEO | Sell | 6,214.00 | 63.65 | 395,521.10 | 286,200.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004532/0001562180-18-004532-index.htm |
| 2020-01-17 | Curran Simpson | SVP, Product Development & CTO | Buy | 800.00 | 35.80 | 28,640.00 | 29,070.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000454/0001562180-20-000454-index.htm |
| 2018-11-12 | Kenneth T. Mills | President and CEO | Sell | 13,586.00 | 62.85 | 853,880.10 | 292,414.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004532/0001562180-18-004532-index.htm |
| 2020-01-14 | DONALD J JR HAYDEN | Director | Buy | 30,000.00 | 0.85 | 25,500.00 | 30,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000391/0001562180-20-000391-index.htm |
| 2018-12-31 | Patrick J. Christmas | SVP, General Counsel | Buy | 337.00 | 35.66 | 12,016.58 | 3,006.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019000222/0001562180-19-000222-index.htm |
| 2019-04-18 | Patrick J. Christmas | SVP, General Counsel | Sell | 100.00 | 55.50 | 5,550.00 | 3,006.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002324/0001562180-19-002324-index.htm |
| 2019-06-18 | Patrick J. Christmas | SVP, General Counsel | Sell | 100.00 | 54.75 | 5,475.00 | 3,006.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003602/0001562180-19-003602-index.htm |
| 2019-12-09 | Curran Simpson | SVP, Product Development & CTO | Sell | 9,399.00 | 43.40 | 407,916.60 | 30,101.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019006017/0001562180-19-006017-index.htm |
| 2019-06-30 | Patrick J. Christmas | SVP, General Counsel | Buy | 52.00 | 36.83 | 1,915.16 | 3,058.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004025/0001562180-19-004025-index.htm |
| 2019-07-18 | Patrick J. Christmas | SVP, General Counsel | Sell | 100.00 | 50.00 | 5,000.00 | 3,058.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004025/0001562180-19-004025-index.htm |
| 2019-07-19 | Patrick J. Christmas | SVP, General Counsel | Sell | 4,900.00 | 50.03 | 245,147.00 | 3,058.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004025/0001562180-19-004025-index.htm |
| 2018-11-05 | Kenneth T. Mills | President and CEO | Sell | 4,709.00 | 69.92 | 329,253.28 | 306,000.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004451/0001562180-18-004451-index.htm |
| 2019-04-18 | Patrick J. Christmas | SVP, General Counsel | Sell | 885.00 | 54.66 | 48,374.10 | 3,106.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002324/0001562180-19-002324-index.htm |
| 2019-06-18 | Patrick J. Christmas | SVP, General Counsel | Sell | 1,934.00 | 53.29 | 103,062.86 | 3,106.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003602/0001562180-19-003602-index.htm |
| 2018-11-05 | Kenneth T. Mills | President and CEO | Sell | 3,340.00 | 69.47 | 232,029.80 | 310,709.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004451/0001562180-18-004451-index.htm |
| 2018-11-05 | Kenneth T. Mills | President and CEO | Sell | 3,635.00 | 68.27 | 248,161.45 | 314,049.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004451/0001562180-18-004451-index.htm |
| 2019-07-18 | Patrick J. Christmas | SVP, General Counsel | Buy | 100.00 | 19.50 | 1,950.00 | 3,158.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004025/0001562180-19-004025-index.htm |
| 2018-11-05 | Kenneth T. Mills | President and CEO | Sell | 4,816.00 | 67.16 | 323,442.56 | 317,684.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004451/0001562180-18-004451-index.htm |
| 2020-01-17 | DONALD J JR HAYDEN | Director | Buy | 3,200.00 | 0.85 | 2,720.00 | 3,200.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020000452/0001562180-20-000452-index.htm |
| 2018-11-05 | Kenneth T. Mills | President and CEO | Sell | 3,500.00 | 66.29 | 232,015.00 | 322,500.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004451/0001562180-18-004451-index.htm |
| 2018-12-18 | Patrick J. Christmas | SVP, General Counsel | Sell | 2,055.00 | 47.85 | 98,331.75 | 3,389.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018005060/0001562180-18-005060-index.htm |
| 2020-02-11 | Curran Simpson | SVP, Product Development & CTO | Sell | 3,692.00 | 51.37 | 189,658.04 | 3,948.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001112/0001562180-20-001112-index.htm |
| 2018-11-16 | Curran Simpson | SVP, Technical Operations | Sell | 15,494.00 | 64.71 | 1,002,616.74 | 39,500.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004631/0001562180-18-004631-index.htm |
| 2019-02-05 | Curran Simpson | SVP, Product Development & CTO | Sell | 43,832.00 | 50.08 | 2,195,106.56 | 39,500.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019000815/0001562180-19-000815-index.htm |
| 2019-02-25 | Curran Simpson | SVP, Product Development & CTO | Sell | 5,300.00 | 54.05 | 286,465.00 | 39,500.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019001472/0001562180-19-001472-index.htm |
| 2019-05-28 | Curran Simpson | SVP, Product Development & CTO | Sell | 18,000.00 | 50.00 | 900,000.00 | 39,500.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003180/0001562180-19-003180-index.htm |
| 2019-04-18 | Patrick J. Christmas | SVP, General Counsel | Sell | 1,115.00 | 53.67 | 59,842.05 | 3,991.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002324/0001562180-19-002324-index.htm |
| 2020-02-10 | Curran Simpson | SVP, Product Development & CTO | Buy | 14,928.00 | 22.00 | 328,416.00 | 41,829.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001112/0001562180-20-001112-index.htm |
| 2019-02-25 | Curran Simpson | SVP, Product Development & CTO | Buy | 5,300.00 | 35.80 | 189,740.00 | 44,800.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019001472/0001562180-19-001472-index.htm |
| 2018-11-05 | Stephen Yoo | Chief Medical Officer | Sell | 3,854.00 | 69.54 | 268,007.16 | 4,627.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004452/0001562180-18-004452-index.htm |
| 2018-11-20 | LUKE M BESHAR | Director | Buy | 4,688.00 | 22.00 | 103,136.00 | 4,688.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm |
| 2019-02-05 | Curran Simpson | SVP, Product Development & CTO | Buy | 8,450.00 | 35.80 | 302,510.00 | 47,950.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019000815/0001562180-19-000815-index.htm |
| 2019-06-18 | Patrick J. Christmas | SVP, General Counsel | Sell | 2,966.00 | 52.74 | 156,426.84 | 5,040.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003602/0001562180-19-003602-index.htm |
| 2018-12-03 | Stephen Yoo | Chief Medical Officer | Sell | 13,053.00 | 60.35 | 787,748.55 | 507.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004850/0001562180-18-004850-index.htm |
| 2019-04-18 | Patrick J. Christmas | SVP, General Counsel | Sell | 2,900.00 | 52.55 | 152,395.00 | 5,106.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002324/0001562180-19-002324-index.htm |
| 2020-02-10 | Curran Simpson | SVP, Product Development & CTO | Buy | 12,479.00 | 35.80 | 446,748.20 | 54,308.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001112/0001562180-20-001112-index.htm |
| 2018-12-18 | Patrick J. Christmas | SVP, General Counsel | Sell | 2,225.00 | 46.79 | 104,107.75 | 5,444.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018005060/0001562180-18-005060-index.htm |
| 2018-11-16 | Curran Simpson | SVP, Technical Operations | Sell | 6,505.00 | 63.64 | 413,978.20 | 54,994.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004631/0001562180-18-004631-index.htm |
| 2018-11-27 | LUKE M BESHAR | Director | Buy | 4,687.00 | 22.00 | 103,114.00 | 5,570.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004727/0001562180-18-004727-index.htm |
| 2019-05-28 | Curran Simpson | SVP, Product Development & CTO | Buy | 18,000.00 | 22.00 | 396,000.00 | 57,500.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003180/0001562180-19-003180-index.htm |
| 2018-11-19 | LUKE M BESHAR | Director | Sell | 600.00 | 62.81 | 37,686.00 | 600.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm |
| 2018-11-16 | Curran Simpson | SVP, Technical Operations | Sell | 6,883.00 | 62.79 | 432,183.57 | 61,499.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004631/0001562180-18-004631-index.htm |
| 2018-11-19 | Stephen Yoo | Chief Medical Officer | Sell | 9,092.00 | 59.61 | 541,974.12 | 6,261.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004642/0001562180-18-004642-index.htm |
| 2019-03-12 | Olivier Danos | Chief Scientific Officer | Buy | 5,000.00 | 20.35 | 101,750.00 | 6,500.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019001906/0001562180-19-001906-index.htm |
| 2019-04-15 | Olivier Danos | Chief Scientific Officer | Sell | 1,000.00 | 53.09 | 53,090.00 | 6,500.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002295/0001562180-19-002295-index.htm |
| 2019-04-18 | Patrick J. Christmas | SVP, General Counsel | Buy | 3,541.00 | 12.10 | 42,846.10 | 6,547.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002324/0001562180-19-002324-index.htm |
| 2018-11-16 | Curran Simpson | SVP, Technical Operations | Sell | 4,000.00 | 61.91 | 247,640.00 | 68,382.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004631/0001562180-18-004631-index.htm |
| 2018-11-16 | Curran Simpson | SVP, Technical Operations | Buy | 32,882.00 | 22.00 | 723,404.00 | 72,382.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004631/0001562180-18-004631-index.htm |
| 2019-04-15 | Olivier Danos | Chief Scientific Officer | Sell | 1,000.00 | 52.23 | 52,230.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002295/0001562180-19-002295-index.htm |
| 2020-02-11 | Curran Simpson | SVP, Product Development & CTO | Sell | 8,872.00 | 50.13 | 444,753.36 | 7,640.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001112/0001562180-20-001112-index.htm |
| 2018-12-18 | Patrick J. Christmas | SVP, General Counsel | Buy | 5,000.00 | 12.10 | 60,500.00 | 7,669.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018005060/0001562180-18-005060-index.htm |
| 2018-11-20 | LUKE M BESHAR | Director | Buy | 2,988.00 | 12.74 | 38,067.12 | 7,676.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm |
| 2019-07-19 | Patrick J. Christmas | SVP, General Counsel | Buy | 4,900.00 | 19.50 | 95,550.00 | 7,958.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004025/0001562180-19-004025-index.htm |
| 2019-04-18 | Patrick J. Christmas | SVP, General Counsel | Buy | 1,459.00 | 19.50 | 28,450.50 | 8,006.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002324/0001562180-19-002324-index.htm |
| 2019-06-18 | Patrick J. Christmas | SVP, General Counsel | Buy | 5,000.00 | 12.10 | 60,500.00 | 8,006.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019003602/0001562180-19-003602-index.htm |
| 2019-09-12 | Patrick J. Christmas | SVP, General Counsel | Buy | 5,000.00 | 12.10 | 60,500.00 | 8,058.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019004820/0001562180-19-004820-index.htm |
| 2019-02-05 | Curran Simpson | SVP, Product Development & CTO | Buy | 32,882.00 | 22.00 | 723,404.00 | 80,832.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019000815/0001562180-19-000815-index.htm |
| 2019-02-05 | Curran Simpson | SVP, Product Development & CTO | Buy | 1,875.00 | 19.50 | 36,562.50 | 82,707.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019000815/0001562180-19-000815-index.htm |
| 2019-02-05 | Curran Simpson | SVP, Product Development & CTO | Buy | 625.00 | 13.09 | 8,181.25 | 83,332.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019000815/0001562180-19-000815-index.htm |
| 2018-11-05 | Stephen Yoo | Chief Medical Officer | Sell | 3,700.00 | 68.22 | 252,414.00 | 8,481.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004452/0001562180-18-004452-index.htm |
| 2019-04-15 | Olivier Danos | Chief Scientific Officer | Buy | 2,000.00 | 20.35 | 40,700.00 | 8,500.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218019002295/0001562180-19-002295-index.htm |
| 2018-11-27 | LUKE M BESHAR | Director | Buy | 883.00 | 49.45 | 43,664.35 | 883.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004727/0001562180-18-004727-index.htm |
| 2018-11-19 | LUKE M BESHAR | Director | Buy | 6,250.00 | 18.85 | 117,812.50 | 8,854.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm |
| 2020-02-10 | Curran Simpson | SVP, Product Development & CTO | Sell | 44,429.00 | 50.22 | 2,231,224.38 | 9,879.00 | https://www.sec.gov/Archives/edgar/data/1590877/000156218020001112/0001562180-20-001112-index.htm |